Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sufentanil vs oliceridine for postoperative analgesia in AICU patients
ChiCTR2400083772Phase 4Not yet recruiting
- Sponsor
- Wu Jieping Medical Foundation Committee
- Start
- Apr 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in acute pain comparing Oliceridine analgesic group with Sufentanil analgesic group (2 arms). Primary endpoints: Numeric Rating Scale for pain, Changes in interleukin-6 levels and 1 more. Planned start Apr 2024; status: not yet recruiting.
02
Drugs
oliceridinesufentanil
03
Conditions
acute pain
Beyond the preview
Go deeper on ChiCTR2400083772.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400083772.